Platform top 10

Life Sciences Innovation Hub Driving Discovery, Unveiling The Mysteries of Life

At the forefront of life sciences, our high throughput sequencing platforms is a formidable ally in your pursuit of research excellence.

 

HomePlatform

Omics empower have integrated a suite of cutting-edge technologies, including 10x Genomics, Illumina, Mobidrop, and sTomics, to provide you with tailored genetic sequencing and analysis services.

 

Explore Gene Expression with Precision and Efficiency

 

10x Genomics

Reveal the complexities of cellular diversity through single-cell gene expression analysis.

 

Image source: https://www.10xgenomics.com/cn

 

MobiDrop

Utilize the precision of microfluidic technology for single-cell gene sequencing and cell sorting.

 

Image source: https://www.mobidrop.com/

 

Unveiling Our Milestones a Journey of Innovation and Excellence

Omics empower possess top-notch single-cell technology globally, with 3 major single-cell transcriptome analysis platforms: 10xGenomics, BD Rhapsody, MobiNova, and 4 major spatial transcriptome platforms: 10x Genomics Visium, CytAssist, Xenium, and BGl Spatial Omics, ensuring our services are at the forefront of the industry.

 

We are proud to have assisted our clients in publishing over 300 articles related to single-cell technology.

 

We are grateful that our single-cell technology has been acknowledged in over 150 articles, with 36 specifically thanking our bioinformatics services, and we have co-authored 12 articles in the field of spatial transcriptomics.

 

Enjoyed this article? Stay informed by joining our newsletter!

Comments

You must be logged in to post a comment.

About Author

Shanghai OE Biotech Co., Ltd. was founded in 2009 in Shanghai, China, a leading CRO company in the Chinese market. OE Biotech provides multi-omics technology services to a wide range of top universities, hospitals, research institutions and technology-based companies, accelerating the research process of each organization and unit, and using biotechnology to achieve the success of others and benefit the public.The company has built a complete multi-omics testing service platform and a multi-omics big data analysis platform, providing genome, transcriptome, epigenome, microbiome, proteome, metabolome and other whole-omics testing services; and continues to follow the progress of Omics technology. In recent years, the company has gradually developed a comprehensive advantage in single-cell sequencing technology, spatial multi-omics technology, multi-omics joint analysis, etc., and the revenue of such innovative business ranks first in the Chinese market. The company has nearly 600 employees, most of whom have bachelor's degree or above, and nearly half of them have master's degree or doctor's degree. https://www.omicsempower.com/